Foundation for Sarcoidosis Research Advanced Cures Registry (FSR-SARC Registry)
NCT06234384 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 6833
Last updated 2025-09-19
Summary
The goal of the study is to create a longitudinal record of patient reported outcomes for people living with sarcoidosis that maintains privacy. Patients report on the following: demographics, disease symptoms, diagnostic journey, provider experience, disease treatment, and burden of disease. Patients can also link their Electronic Health Records (EHR). The goal is to create a natural history of sarcoidosis, support research, and better understand the needs of the sarcoidosis community.
Conditions
- Sarcoidosis
Interventions
- OTHER
-
Sarcoidosis diagnosis
Participants have been diagnosed with sarcoidosis.
Sponsors & Collaborators
-
Foundation for Sarcoidosis Research
lead OTHER
Eligibility
- Min Age
- 7 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-07-31
- Primary Completion
- 2033-06-30
- Completion
- 2033-07-31
Countries
- United States
Study Locations
More Related Trials
-
Fresolimumab In Systemic Sclerosis
NCT01284322 ·Status: COMPLETED ·Phase: PHASE1
-
RCT of Nintedanib in Fibrotic Sarcoidosis
NCT06479603 ·Status: RECRUITING ·Phase: PHASE4
-
Stromal Gene Expression During Pulmonary Sarcoidosis
NCT00837668 ·Status: TERMINATED
-
Immunological Mechanisms in Sarcoidosis
NCT06576505 ·Status: RECRUITING
-
Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome.
NCT04904146 ·Status: RECRUITING
-
A Phase 2 Study With CC-220 in Skin Sarcoidosis
NCT02192489 ·Status: WITHDRAWN ·Phase: PHASE2
-
Longitudinal Spatial Frequency Domain Imaging Study
NCT05672992 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Western Sweden Systemic Sclerosis Project
NCT07345052 ·Status: RECRUITING
-
SCOT Scleroderma Treatment Alternative Registry (STAR Registry)
NCT00860548 ·Status: COMPLETED
-
Comparing and Combining Bortezomib and Mycophenolate in SSc Pulmonary Fibrosis
NCT02370693 ·Status: COMPLETED ·Phase: PHASE2
-
Diffuse Cutaneous Scleroderma (DSSc) SFDI Study
NCT07090226 ·Status: RECRUITING ·Phase: NA
-
Utility of Breath-holding Test in Systemic Sclerosis
NCT04484948 ·Status: COMPLETED ·Phase: NA
-
Stem Cell Factor, a Potential Biological Marker of Skin Involvement in Systemic Sclerosis?
NCT05482594 ·Status: UNKNOWN
-
Tissue and Serum Level of NLRP1, NLRP3 and Il-18 in Early Stages of mf Patients
NCT06066554 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Study of Skin Tumors in Tuberous Sclerosis
NCT00001975 ·Status: RECRUITING
-
Fibrous Dysplasia, McCune-Albright Syndrome Patient Registry
NCT03231644 ·Status: RECRUITING
-
The Scleroderma Biorepository and Pathogenesis Study (STOP Scleroderma)
NCT02887495 ·Status: COMPLETED
-
Familial Systemic Scleroderma
NCT07343115 ·Status: RECRUITING
-
A Safety and Efficacy Study of FCR001 in Adults With Rapidly Progressive Diffuse Cutaneous Systemic Sclerosis
NCT05098145 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Hidradenitis Suppurativa Prospective Observational Registry and Biospecimen Repository
NCT04115566 ·Status: RECRUITING
-
The Efficacy and Safety of CC-10004 in Chronic Cutaneous Sarcoidosis
NCT00794274 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Profibrosing Role of B Lymphocytes in Patients With Systemic Sclerosis.
NCT03559465 ·Status: COMPLETED ·Phase: NA
-
Morbidity and Mortality Follow Up for the Scleroderma Lung Study
NCT01762449 ·Status: COMPLETED
-
SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)
NCT07021495 ·Status: RECRUITING
-
A Study in People With Systemic Sclerosis to Test Whether Avenciguat (BI 685509) Has an Effect on Lung Function and Other Systemic Sclerosis Symptoms
NCT05559580 ·Status: COMPLETED ·Phase: PHASE2